Akron Pharma, Inc.: Drug Recall

Recall #D-1352-2022 · 08/04/2022

Class III: Low Risk

Recall Details

Recall Number
D-1352-2022
Classification
Class III
Product Type
Drug
Recalling Firm
Akron Pharma, Inc.
Status
Terminated
Date Initiated
08/04/2022
Location
Fairfield, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
301,382 bottles

Reason for Recall

Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.

Product Description

Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count bottle (NDC 71399-8024-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ

Distribution Pattern

Product was distributed to 6 distributors/wholesalers who may have further distributed the product.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.